Form D · Other Health Care

Landsdowne Labs, LLC

Fairfield, CT · CIK 0001730518

Offering snapshot reported Oct 8, 2021 · SEC filing

Reported sold: $2.16M
Investors reported: 42
Minimum accepted: $10K
First sale: Oct 14, 2020

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$463,950 → $2,159,376
Reported investors8 → 42
Minimum accepted$25,000 → $10,000

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 8, 2021	Amendment	$2,159,376	$1,695,426vs Oct 23, 2020	42	SEC filing
Oct 23, 2020	Initial	$463,950	No comparison	8	SEC filing
Feb 6, 2018	Initial	$1,644,999	No comparison	10	SEC filing

Offering details

Securities: Other
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $12.7K
Finders' fees: $0
Form D file number: 021-378719

Convertible Promissory Note

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Hubble Investments LLC	289415	Hubble Investments LLC · CRD 289415

Source: Form D, filed Oct 8, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Melissa Fensterstock	Director, Executive
Daniel Goldberg	Director
Jeffrey Karp	Executive, Promoter
Robert Langer	Director
Bryan Laulicht	Executive, Promoter
David Lucchino	Director
Patrick O'neill	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

1073 N Benson Road
Fairfield, CT, 06824